Privia Health Group Inc (PRVA) PT Lowered to $28 at Truist Securities
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
JPMorgan Positive on Privia Health Group Inc (PRVA) Following Earnings, Management Call
February 27, 2024 12:09 PM ESTJPMorgan analyst Lisa C. Gill reiterated an Overweight rating and $20.00 price target on Privia Health Group Inc (NASDAQ: PRVA)
The analyst comments "We are positive on PRVA as the companys notably more conservative and contrarian approach to capitated risk is driving greater financial... More
Privia Health Group, Inc. (PRVA) Tops Q4 EPS by 11c, provides guidance
February 27, 2024 6:15 AM ESTPrivia Health Group, Inc. (NASDAQ: PRVA) reported Q4 EPS of $0.15, $0.11 better than the analyst estimate of $0.04. Revenue for the quarter came in at $440.8 million versus the consensus estimate of $426.53 million.
GUIDANCE:
Privia Health Group, Inc. sees FY 2024 revenue of $1.6-1.675 billion,... More
